Literature DB >> 27288038

Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease.

Theodore K Marras1, Michael A Campitelli2, Jeffrey C Kwong3, Hong Lu2, Sarah K Brode4, Alex Marchand-Austin5, Andrea S Gershon6, Frances B Jamieson7.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27288038     DOI： 10.1183/13993003.00033-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  Diagnosis of nontuberculous mycobacterial disease in the era of surveillance chest CT scans.

Authors:  Andrew Calzadilla; Greg Holt; Michael Campos; Mehdi Mirsaeidi
Journal:  Infection       Date:  2018-10-08       Impact factor: 3.553

Review 2.  Infection Sources of a Common Non-tuberculous Mycobacterial Pathogen, Mycobacterium avium Complex.

Authors:  Yukiko Nishiuchi; Tomotada Iwamoto; Fumito Maruyama
Journal:  Front Med (Lausanne)       Date:  2017-03-07

Review 3.  Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK.

Authors:  Marc Lipman; Joanne Cleverley; Tom Fardon; Besma Musaddaq; Daniel Peckham; Roald van der Laan; Paul Whitaker; Jacqui White
Journal:  BMJ Open Respir Res       Date:  2020-06

4.  Aggregation of Nontuberculous Mycobacteria Is Regulated by Carbon-Nitrogen Balance.

Authors:  William H DePas; Megan Bergkessel; Dianne K Newman
Journal:  mBio       Date:  2019-08-13       Impact factor: 7.867

5.  Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis.

Authors:  Yannick Vande Weygaerde; Nina Cardinaels; Peter Bomans; Taeyang Chin; Jerina Boelens; Emmanuel André; Eva Van Braeckel; Natalie Lorent
Journal:  BMC Infect Dis       Date:  2019-12-17       Impact factor: 3.090

6.  Intersectoral Cost of Treating Pulmonary Non-Tuberculosis Mycobacterial Disease (NTM-PD) in Germany-A Change of Perspective in Disease Management.

Authors:  Roland Diel; Pontus Mertsch
Journal:  Int J Environ Res Public Health       Date:  2019-10-09       Impact factor: 3.390

7.  Exacerbation of Mycobacterium avium pulmonary infection by comorbid allergic asthma is associated with diminished mycobacterium-specific Th17 responses.

Authors:  Yeeun Bak; Sang Chul Park; Dahee Shim; Yura Ha; Jumi Lee; Hongmin Kim; Kee Woong Kwon; Joo-Heon Yoon; Sung Jae Shin
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

8.  Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections.

Authors:  Grace Wang; Jack T Stapleton; Arthur W Baker; Nadine Rouphael; C Buddy Creech; Hana M El Sahly; Jason E Stout; Lisa Jackson; Edward Charbek; Francisco J Leyva; Kay M Tomashek; Melinda Tibbals; Aaron Miller; Sharon Frey; Samson Niemotka; Timothy L Wiemken; Nour Beydoun; Ghina Alaaeddine; Nicholas Turner; Emmanuel B Walter; Robin Chamberland; Getahun Abate
Journal:  Open Forum Infect Dis       Date:  2022-07-26       Impact factor: 4.423

9.  The Higher Incidence of COVID-19 in Patients With Non-Tuberculous Mycobacterial Pulmonary Disease: A Single Center Experience in Korea.

Authors:  Sang Hyuk Kim; Byung Woo Jhun; Byeong-Ho Jeong; Hye Yun Park; Hojoong Kim; O Jung Kwon; Sun Hye Shin
Journal:  J Korean Med Sci       Date:  2022-08-15       Impact factor: 5.354

10.  Risk factors and secondary care utilisation in a primary care population with non-tuberculous mycobacterial disease in the UK.

Authors:  Eleanor L Axson; Navdeep Bual; Chloe I Bloom; Jennifer K Quint
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-27       Impact factor: 3.267
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.